QZW
- 产品代码
- QZW
- 器械名称
- Over-The-Counter Device To Assess Risk Of Sleep Apnea
- 管理类别
- 第 2 类(Class II)
- 21 CFR 条款
- 21 CFR 868.2378
- FDA 专业组
- Anesthesiology
- 上市路径
- 需提交 510(k) 上市前通告
- 该代码近三年的 510(k)
- 3 件
- 其中 Summary 已存档
- 2 份,可直接下载
- FDA 历史累计 510(k)
- 3 件(全部年份;本站只收录近三年的明细)
FDA 分类定义
An over-the-counter device to assess risk of sleep apnea is intended to provide a notification of the risk of sleep apnea in users who have not been previously diagnosed with sleep apnea. This device uses software algorithms to analyze input sensor signals and provide a risk assessment for sleep apnea. It is not intended to provide a standalone diagnosis, replace traditional methods of diagnosis (e.g., polysomnography), assist clinicians in diagnosing sleep disorders, or be used as an apnea monitor.
该代码近三年的 510(k)(3 件)
| 510(k) 号 | 批准日期 | 申请人 | 器械名称 | 摘要 |
|---|---|---|---|---|
| K261011 | 2026-07-20 | Samsung Electronics Co., Ltd. | Sleep Apnea Feature (v2.0) | |
| K240929 | 2024-09-13 | Apple, Inc. | Sleep Apnea Notification Feature (SANF) | |
| DEN230041 | 2024-02-06 | Samsung Electronics Co., Ltd. | Sleep Apnea Feature | — |
FDA 官方分类页: QZW
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。